Cargando…
Neuroprotection by immunomodulatory agents in animal models of Parkinson’s disease
Parkinson’s disease (PD) is an age-related neurodegenerative disease for which the characteristic motor symptoms emerge after an extensive loss of dopamine containing neurons. The cell bodies of these neurons are present in the substantia nigra, with the nerve terminals being in the striatum. Both i...
Autores principales: | Martinez, Bridget, Peplow, Philip V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126123/ https://www.ncbi.nlm.nih.gov/pubmed/30127102 http://dx.doi.org/10.4103/1673-5374.237108 |
Ejemplares similares
-
Amelioration of Alzheimer’s disease pathology and cognitive deficits by immunomodulatory agents in animal models of Alzheimer’s disease
por: Martinez, Bridget, et al.
Publicado: (2019) -
Altered microRNA expression in animal models of Huntington’s disease and potential therapeutic strategies
por: Martinez, Bridget, et al.
Publicado: (2021) -
MicroRNAs in Parkinson's disease and emerging therapeutic targets
por: Martinez, Bridget, et al.
Publicado: (2017) -
MicroRNA expression in animal models of amyotrophic lateral sclerosis and potential therapeutic approaches
por: Martinez, Bridget, et al.
Publicado: (2021) -
Protective effects of pharmacological therapies in animal models of multiple sclerosis: a review of studies 2014–2019
por: Martinez, Bridget, et al.
Publicado: (2020)